Viewing Study NCT05170334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 8:30 AM
Study NCT ID: NCT05170334
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module